Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.32 is 24% below its 5-year average of 4.38, near the low end of its 5-year range (2.01–10.63).
As of the fiscal period ended Tuesday, June 30, 2026. 17.73% above its 12-month average of 2.82.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.32.
CURRENT RATIO
3.32
CURRENT RATIO AVG TTM
2.82
CURRENT RATIO AVG 3Y
3.51
CURRENT RATIO AVG 5Y
4.38
CURRENT RATIO AVG 10Y
3.95
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+17.73%
CURRENT VS 3Y AVG
-5.42%
CURRENT VS 5Y AVG
-24.23%
CURRENT VS 10Y AVG
-15.86%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-11.45%
vs the sector median at left
Market Cap
$140.31M
Current Ratio
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
Market Cap
$143.90M
Current Ratio
3.96
TTM Avg
1.88
3Y Avg
1.73
5Y Avg
2.58
Market Cap
$144.42M
Current Ratio
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.20
Market Cap
$137.60M
Current Ratio
2.72
TTM Avg
2.55
3Y Avg
3.48
5Y Avg
5.33
Market Cap
$137.40M
Current Ratio
8.73
TTM Avg
6.53
3Y Avg
6.53
5Y Avg
6.53
Market Cap
$145.29M
Current Ratio
10.97
TTM Avg
15.14
3Y Avg
14.12
5Y Avg
22.71
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sutro Biopharma, Inc. (STRO) | $141.12M | 3.32 | 2.82 | 3.51 | 4.38 |
| Immuneering Corporation (IMRX)vs › | $140.31M | 19.47 | 11.39 | 11.91 | 15.23 |
| Nyxoah S.A. (NYXH)vs › | $142.60M | 2.38 | 2.90 | 4.31 | 7.34 |
| Fortress Biotech, Inc. (FBIOP)vs › | $143.90M | 3.96 | 1.88 | 1.73 | 2.58 |
| Alpha Cognition Inc (ACOG)vs › | $139.01M | 9.03 | 11.82 | 6.24 | 5.64 |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.42M | 0.82 | 5.49 | 4.19 | 4.20 |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.60M | 2.72 | 2.55 | 3.48 | 5.33 |
| Atrium Therapeutics, Inc. (RNA)vs › | $137.40M | 8.73 | 6.53 | 6.53 | 6.53 |
| Protara Therapeutics, Inc. (TARA)vs › | $145.29M | 10.97 | 15.14 | 14.12 | 22.71 |
| Organigram Global Inc. (OGI)vs › | $136.55M | 2.61 | 3.59 | 4.71 | 5.61 |
Current Ratio
3.32
Quick Ratio
3.32
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.32 |
| 2026-03-31 | 3.12 |
| 2025-12-31 | 2.01 |
| 2025-09-30 | 2.53 |
| 2025-06-30 | 3.12 |
| 2025-03-31 | 2.16 |
| 2024-12-31 | 2.60 |
| 2024-09-30 | 3.09 |
| 2024-06-30 | 3.41 |
| 2024-03-31 | 4.46 |
| 2023-12-31 | 4.50 |
| 2023-09-30 | 5.18 |
| 2023-06-30 | 6.14 |
| 2023-03-31 | 5.11 |
| 2022-12-31 | 5.31 |
| 2022-09-30 | 5.95 |
| 2022-06-30 | 7.44 |
| 2022-03-31 | 5.90 |
| 2021-12-31 | 5.24 |
| 2021-09-30 | 7.07 |
| 2021-06-30 | 10.63 |
| 2021-03-31 | 11.74 |
| 2020-12-31 | 12.78 |
| 2020-09-30 | 9.77 |
| 2020-06-30 | 7.29 |
| 2020-03-31 | 3.98 |
| 2019-12-31 | 3.90 |
| 2019-09-30 | 3.78 |
| 2019-06-30 | 4.49 |
| 2019-03-31 | 5.67 |
| 2018-12-31 | 5.76 |
| 2018-09-30 | 3.45 |
| 2018-06-30 | 1.57 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.80 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
